# Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study

Study · id `cardio:ct-nct04035824` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04035824](<https://clinicaltrials.gov/study/NCT04035824>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04035824

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 605 participants.

## Technical summary

Registry record NCT04035824. Randomized; double masking; primary purpose treatment. Start 2019-10-08 (actual); primary completion 2024-04-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 605 participants (enrolled count; ClinicalTrials.gov record NCT04035824, source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)
- Started: 2019-10-08 (actual) (ClinicalTrials.gov record NCT04035824, source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)
- Primary completion: 2024-04-12 (actual) (ClinicalTrials.gov record NCT04035824, source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)
- Completion: 2024-04-24 (actual) (ClinicalTrials.gov record NCT04035824, source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04035824, source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04035824-2025-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study
- Condition: Hypertension
- Intervention (Drug): Gastrodia and Uncaria granule
- Intervention (Drug): Placebo of Gastrodia and Uncaria granule
- Lead sponsor: Shanghai Institute of Hypertension
- Lead sponsor class: OTHER
- Collaborator: Ruijin Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Shanghai Institute of Hypertension (`cardio:org-shanghai-institute-of-hypertension`)
- Registry lists this organization as a collaborator: Ruijin Hospital (`cardio:org-ruijin-hospital`)
- Registry lists this organization as a collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-general-hospital-shanghai-jiao-tong-university-237209`)

## Provenance

Content hash: 59ea662f94a3c31f3637d6a07d37c9c80250ea959033360467b128bdade649a1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
